{"id":"https://openalex.org/W3205535255","doi":"https://doi.org/10.1111/ced.14979","title":"Anti\u2010interleukin\u201023 for psoriasis in elderly patients: guselkumab, risankizumab and tildrakizumab in real\u2010world practice","display_name":"Anti\u2010interleukin\u201023 for psoriasis in elderly patients: guselkumab, risankizumab and tildrakizumab in real\u2010world practice","publication_year":2021,"publication_date":"2021-10-13","ids":{"openalex":"https://openalex.org/W3205535255","doi":"https://doi.org/10.1111/ced.14979","mag":"3205535255","pmid":"https://pubmed.ncbi.nlm.nih.gov/34642965","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/9299162"},"language":"en","primary_location":{"id":"doi:10.1111/ced.14979","doi":"https://doi.org/10.1111/ced.14979","is_oa":true,"landing_page_url":"https://doi.org/10.1111/ced.14979","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/ced.14979","source":{"id":"https://openalex.org/S80252431","display_name":"Clinical and Experimental Dermatology","issn_l":"0307-6938","issn":["0307-6938","1365-2230"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical and Experimental Dermatology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/ced.14979","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5025725407","display_name":"Angelo Ruggiero","orcid":"https://orcid.org/0000-0002-4658-7391","observed_orcids":["https://orcid.org/0000-0002-4658-7391"]},"institutions":[{"id":"https://openalex.org/I4210117450","display_name":"Federico II University Hospital","ror":"https://ror.org/02jr6tp70","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210117450","https://openalex.org/I71267560"]},{"id":"https://openalex.org/I71267560","display_name":"University of Naples Federico II","ror":"https://ror.org/05290cv24","country_code":"IT","type":"education","lineage":["https://openalex.org/I71267560"]}],"countries":["IT"],"is_corresponding":true,"raw_author_name":"A. Ruggiero","raw_affiliation_strings":["Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy"],"raw_orcid":"https://orcid.org/0000-0002-4658-7391","affiliations":[{"raw_affiliation_string":"Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy","institution_ids":["https://openalex.org/I4210117450","https://openalex.org/I71267560"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026402548","display_name":"Gabriella Fabbrocini","orcid":"https://orcid.org/0000-0002-0064-1874","observed_orcids":["https://orcid.org/0000-0002-0064-1874"]},"institutions":[{"id":"https://openalex.org/I4210117450","display_name":"Federico II University Hospital","ror":"https://ror.org/02jr6tp70","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210117450","https://openalex.org/I71267560"]},{"id":"https://openalex.org/I71267560","display_name":"University of Naples Federico II","ror":"https://ror.org/05290cv24","country_code":"IT","type":"education","lineage":["https://openalex.org/I71267560"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"G. Fabbrocini","raw_affiliation_strings":["Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy","institution_ids":["https://openalex.org/I4210117450","https://openalex.org/I71267560"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080991532","display_name":"Eleonora Cinelli","orcid":"https://orcid.org/0000-0003-3046-5493","observed_orcids":["https://orcid.org/0000-0003-3046-5493"]},"institutions":[{"id":"https://openalex.org/I4210117450","display_name":"Federico II University Hospital","ror":"https://ror.org/02jr6tp70","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210117450","https://openalex.org/I71267560"]},{"id":"https://openalex.org/I71267560","display_name":"University of Naples Federico II","ror":"https://ror.org/05290cv24","country_code":"IT","type":"education","lineage":["https://openalex.org/I71267560"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"E. Cinelli","raw_affiliation_strings":["Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy"],"raw_orcid":"https://orcid.org/0000-0003-3046-5493","affiliations":[{"raw_affiliation_string":"Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy","institution_ids":["https://openalex.org/I4210117450","https://openalex.org/I71267560"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001540792","display_name":"Sonia Sof\u00eca Ocampo\u2010Garza","orcid":"https://orcid.org/0000-0002-0508-5117","observed_orcids":["https://orcid.org/0000-0002-0508-5117"]},"institutions":[{"id":"https://openalex.org/I169046204","display_name":"Universidad Aut\u00f3noma de Nuevo Le\u00f3n","ror":"https://ror.org/01fh86n78","country_code":"MX","type":"education","lineage":["https://openalex.org/I169046204"]},{"id":"https://openalex.org/I4210132044","display_name":"Hospital Universitario Dr Jos\u00e9 Eleuterio Gonzalez","ror":"https://ror.org/030ms0x66","country_code":"MX","type":"healthcare","lineage":["https://openalex.org/I4210132044"]}],"countries":["MX"],"is_corresponding":false,"raw_author_name":"S. S. Ocampo Garza","raw_affiliation_strings":["Department of Dermatology University Hospital Dr Jos\u00e9 Eleuterio Gonz\u00e1lez Universidad Aut\u00f3noma de Nuevo Le\u00f3n Monterrey Mexico"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Dermatology University Hospital Dr Jos\u00e9 Eleuterio Gonz\u00e1lez Universidad Aut\u00f3noma de Nuevo Le\u00f3n Monterrey Mexico","institution_ids":["https://openalex.org/I169046204","https://openalex.org/I4210132044"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039155196","display_name":"Elisa Camela","orcid":"https://orcid.org/0000-0001-7201-9163","observed_orcids":["https://orcid.org/0000-0001-7201-9163"]},"institutions":[{"id":"https://openalex.org/I4210117450","display_name":"Federico II University Hospital","ror":"https://ror.org/02jr6tp70","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210117450","https://openalex.org/I71267560"]},{"id":"https://openalex.org/I71267560","display_name":"University of Naples Federico II","ror":"https://ror.org/05290cv24","country_code":"IT","type":"education","lineage":["https://openalex.org/I71267560"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"E. Camela","raw_affiliation_strings":["Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy"],"raw_orcid":"https://orcid.org/0000-0001-7201-9163","affiliations":[{"raw_affiliation_string":"Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy","institution_ids":["https://openalex.org/I4210117450","https://openalex.org/I71267560"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5015814702","display_name":"Matteo Megna","orcid":"https://orcid.org/0000-0003-1803-2046","observed_orcids":["https://orcid.org/0000-0003-1803-2046"]},"institutions":[{"id":"https://openalex.org/I4210117450","display_name":"Federico II University Hospital","ror":"https://ror.org/02jr6tp70","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210117450","https://openalex.org/I71267560"]},{"id":"https://openalex.org/I71267560","display_name":"University of Naples Federico II","ror":"https://ror.org/05290cv24","country_code":"IT","type":"education","lineage":["https://openalex.org/I71267560"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"M. Megna","raw_affiliation_strings":["Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy"],"raw_orcid":"https://orcid.org/0000-0003-1803-2046","affiliations":[{"raw_affiliation_string":"Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy","institution_ids":["https://openalex.org/I4210117450","https://openalex.org/I71267560"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5025725407"],"corresponding_institution_ids":["https://openalex.org/I4210117450","https://openalex.org/I71267560"],"apc_list":{"value":2050,"currency":"GBP","value_usd":3100},"apc_paid":{"value":2050,"currency":"GBP","value_usd":3100},"fwci":6.2213,"has_fulltext":true,"cited_by_count":99,"citation_normalized_percentile":{"value":0.97881207,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":99,"max":100},"biblio":{"volume":"47","issue":"3","first_page":"561","last_page":"567"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10469","display_name":"Psoriasis: Treatment and Pathogenesis","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10469","display_name":"Psoriasis: Treatment and Pathogenesis","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10837","display_name":"Dermatology and Skin Diseases","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11092","display_name":"Spondyloarthritis Studies and Treatments","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/psoriasis","display_name":"psoriasis","score":0.9340000152587891},{"id":"https://openalex.org/keywords/elderly-patients","display_name":"elderly patients","score":0.9729999899864197},{"id":"https://openalex.org/keywords/anti-il-23-therapy","display_name":"anti-IL-23 therapy","score":0.8199999928474426},{"id":"https://openalex.org/keywords/guselkumab","display_name":"guselkumab","score":0.9950000047683716},{"id":"https://openalex.org/keywords/risankizumab","display_name":"risankizumab","score":1.0},{"id":"https://openalex.org/keywords/tildrakizumab","display_name":"tildrakizumab","score":1.0},{"id":"https://openalex.org/keywords/biologic-efficacy","display_name":"biologic efficacy","score":0.6110000014305115},{"id":"https://openalex.org/keywords/biologic-safety","display_name":"biologic safety","score":0.777999997138977},{"id":"https://openalex.org/keywords/pasi-90","display_name":"PASI 90","score":0.734000027179718},{"id":"https://openalex.org/keywords/treatment-discontinuation","display_name":"treatment discontinuation","score":0.7490000128746033},{"id":"https://openalex.org/keywords/real-world-evidence","display_name":"real-world evidence","score":0.6430000066757202},{"id":"https://openalex.org/keywords/comparative-effectiveness","display_name":"comparative effectiveness","score":0.5839999914169312},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.42500001192092896},{"id":"https://openalex.org/keywords/comorbidity","display_name":"comorbidities","score":0.6119999885559082},{"id":"https://openalex.org/keywords/immunosuppression","display_name":"immunosuppression","score":0.44200000166893005}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9192577600479126},{"id":"https://openalex.org/C2780564577","wikidata":"https://www.wikidata.org/wiki/Q179945","display_name":"Psoriasis","level":2,"score":0.7296447157859802},{"id":"https://openalex.org/C156730664","wikidata":"https://www.wikidata.org/wiki/Q23308590","display_name":"Interleukin 23","level":4,"score":0.5547703504562378},{"id":"https://openalex.org/C2777011040","wikidata":"https://www.wikidata.org/wiki/Q390643","display_name":"Psoriasis Area and Severity Index","level":3,"score":0.5116053223609924},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4975123703479767},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.40700608491897583},{"id":"https://openalex.org/C47348012","wikidata":"https://www.wikidata.org/wiki/Q99486570","display_name":"Interleukin 17","level":3,"score":0.34470707178115845},{"id":"https://openalex.org/C2778690821","wikidata":"https://www.wikidata.org/wiki/Q212354","display_name":"Cytokine","level":2,"score":0.04332125186920166}],"mesh":[{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001688","descriptor_name":"Biological Products","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D001688","descriptor_name":"Biological Products","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D003879","descriptor_name":"Dermatologic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D003879","descriptor_name":"Dermatologic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011565","descriptor_name":"Psoriasis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D011565","descriptor_name":"Psoriasis","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D012074","descriptor_name":"Remission Induction","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012189","descriptor_name":"Retrospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017668","descriptor_name":"Age of Onset","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D053760","descriptor_name":"Interleukin-23 Subunit p19","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1111/ced.14979","doi":"https://doi.org/10.1111/ced.14979","is_oa":true,"landing_page_url":"https://doi.org/10.1111/ced.14979","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/ced.14979","source":{"id":"https://openalex.org/S80252431","display_name":"Clinical and Experimental Dermatology","issn_l":"0307-6938","issn":["0307-6938","1365-2230"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical and Experimental Dermatology","raw_type":"journal-article"},{"id":"pmid:34642965","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/34642965","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical and experimental dermatology","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:9299162","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC9299162/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clin Exp Dermatol","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1111/ced.14979","doi":"https://doi.org/10.1111/ced.14979","is_oa":true,"landing_page_url":"https://doi.org/10.1111/ced.14979","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/ced.14979","source":{"id":"https://openalex.org/S80252431","display_name":"Clinical and Experimental Dermatology","issn_l":"0307-6938","issn":["0307-6938","1365-2230"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical and Experimental Dermatology","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W3205535255.pdf","grobid_xml":"https://content.openalex.org/works/W3205535255.grobid-xml"},"referenced_works_count":34,"referenced_works":["https://openalex.org/W1998836331","https://openalex.org/W2020230174","https://openalex.org/W2030605573","https://openalex.org/W2031225991","https://openalex.org/W2034601372","https://openalex.org/W2075066605","https://openalex.org/W2095756367","https://openalex.org/W2122789184","https://openalex.org/W2171240759","https://openalex.org/W2329071207","https://openalex.org/W2570140560","https://openalex.org/W2570141807","https://openalex.org/W2623888527","https://openalex.org/W2697574135","https://openalex.org/W2790556484","https://openalex.org/W2808230287","https://openalex.org/W2884907608","https://openalex.org/W2887412253","https://openalex.org/W2901042984","https://openalex.org/W2910616351","https://openalex.org/W2944224722","https://openalex.org/W2967449819","https://openalex.org/W2985580761","https://openalex.org/W2999183880","https://openalex.org/W3001336221","https://openalex.org/W3006531120","https://openalex.org/W3021254823","https://openalex.org/W3041168317","https://openalex.org/W3044878676","https://openalex.org/W3048245109","https://openalex.org/W3096784794","https://openalex.org/W3111570347","https://openalex.org/W3131268984","https://openalex.org/W3136709547"],"related_works":["https://openalex.org/W4414204534","https://openalex.org/W4392772533","https://openalex.org/W7166220015","https://openalex.org/W7169473144","https://openalex.org/W3213569044","https://openalex.org/W4281288090","https://openalex.org/W4384522926","https://openalex.org/W4317615528","https://openalex.org/W7117307691","https://openalex.org/W4387930670"],"abstract_inverted_index":{"BACKGROUND:":[0],"Elderly":[1],"patients":[2,12,33,64,96,150,234,244,276],"(aged":[3],"\u2265":[4,98],"65":[5,99],"years)":[6],"represent":[7],"an":[8],"increasing":[9],"proportion":[10],"of":[11,17,32,76,115,233,259,266,275,330,333],"with":[13,65,101,108],"psoriasis":[14],"and":[15,37,70,74,79,133,178,182,194,200,223,227,229,238,272,277,299,305,322],"15%":[16],"these":[18],"have":[19,56],"moderate":[20,102],"to":[21,45,103,139,318,323],"severe":[22,104],"disease.":[23],"Biologics":[24],"are":[25,40,296,316],"being":[26,49],"used":[27],"frequently":[28],"in":[29,62,81,84,144,175,187,302,327],"this":[30,331],"group":[31,120,332],"even":[34],"though":[35],"safety":[36,73],"efficacy":[38,75],"data":[39,55,214,315],"limited.":[41],"In":[42,147],"addition,":[43],"owing":[44,138],"anti-interleukin":[46],"(IL)-23":[47],"therapies":[48,294],"a":[50,90],"relatively":[51],"recent":[52,142],"option,":[53],"no":[54,308],"been":[57],"reported":[58],"about":[59],"their":[60,325],"use":[61],"elderly":[63,85,303],"psoriasis.":[66],"AIM:":[67],"To":[68],"evaluate":[69],"compare":[71],"the":[72,116,123,204,219,254,260,267,281,328],"guselkumab,":[77,109,286],"risankizumab":[78,110,220],"tildrakizumab":[80],"real-world":[82],"practice":[83],"patients.":[86,334],"METHODS:":[87],"This":[88],"was":[89,196,307],"single-centre":[91],"retrospective":[92,264],"study":[93,117,261],"that":[94,231],"enrolled":[95,152],"aged":[97],"years":[100],"plaque":[105],"psoriasis,":[106],"treated":[107],"or":[111,209],"tildrakizumab.":[112],"The":[113,257,291],"length":[114],"for":[118,127,131,136,218,280,285,288],"each":[119],"depended":[121],"on":[122,156,161,166,212],"drug":[124],"(44":[125],"weeks":[126,130,135],"risankisumab,":[128],"40":[129,208],"guselkumab":[132,224],"28":[134],"tildrakizumab,":[137],"its":[140,263],"more":[141,314],"availability":[143],"Italy).":[145],"RESULTS:":[146],"total,":[148],"34":[149],"were":[151,215,251],"(n":[153],"=":[154,159,164],"20":[155],"guselkumab;":[157],"n":[158,163],"8":[160],"risankizumab;":[162],"6":[165],"tildrakizumab).":[167,289],"At":[168,203],"Week":[169,191],"4,":[170],"29.4%":[171],"reached":[172,184,197,236,241],"90%":[173],"improvement":[174,186],"Psoriasis":[176],"Area":[177],"Severity":[179],"Index":[180],"(PASI90)":[181],"8.8%":[183],"100%":[185],"PASI":[188],"(PASI100);":[189],"at":[190],"28,":[192],"PASI90":[193,237],"PASI100":[195],"by":[198],"58.8%":[199],"29.4%,":[201],"respectively.":[202],"final":[205],"follow-up":[206,278],"(Week":[207,221,225],"44,":[210],"depending":[211],"drug),":[213],"available":[216],"only":[217],"40)":[222],"44)":[226],"groups,":[228],"showed":[230],"71.4%":[232],"had":[235,240],"53.5%":[239],"PASI100.":[242],"Four":[243],"(11.7%)":[245],"discontinued":[246],"treatment.":[247],"No":[248],"significant":[249,309],"differences":[250],"found":[252],"between":[253,311],"three":[255,292],"groups.":[256],"limitations":[258],"included":[262],"nature":[265],"study,":[268],"small":[269],"sample":[270],"size,":[271],"different":[273,282],"numbers":[274],"duration":[279],"groups":[283],"(highest":[284],"lowest":[287],"CONCLUSION:":[290],"anti-IL-23":[293],"assessed":[295],"promising,":[297],"safe":[298],"effective":[300],"options":[301],"patients,":[304],"there":[306],"difference":[310],"them.":[312],"However,":[313],"needed":[317],"confirm":[319],"our":[320],"results":[321],"understand":[324],"role":[326],"management":[329]},"counts_by_year":[{"year":2026,"cited_by_count":11},{"year":2025,"cited_by_count":20},{"year":2024,"cited_by_count":15},{"year":2023,"cited_by_count":15},{"year":2022,"cited_by_count":38}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2021-10-25T00:00:00"}